Sid blood group system
Sid blood group system is a blood group system recognized by the International Society of Blood Transfusion (ISBT). It is one of the 36 human blood group systems currently identified by the ISBT. The Sid blood group system was named after the first identified antibody, anti-Sid, which was discovered in 2002.
History[edit | edit source]
The Sid blood group system was discovered in 2002 when a new antibody, anti-Sid, was identified in the serum of a woman who had been transfused multiple times. The antibody was named Sid after the patient's initials. The discovery of this new blood group system has expanded our understanding of human blood and its compatibility for blood transfusion.
Characteristics[edit | edit source]
The Sid blood group system is characterized by the presence or absence of the Sid antigen on the surface of red blood cells. Individuals who have the Sid antigen are classified as Sid positive, while those who lack the antigen are classified as Sid negative. The Sid antigen is a protein that is encoded by the SID gene.
Clinical significance[edit | edit source]
The clinical significance of the Sid blood group system lies in its potential to cause hemolytic disease of the newborn (HDN) and hemolytic transfusion reaction (HTR). If a Sid negative individual is transfused with Sid positive blood, the recipient's immune system may produce anti-Sid antibodies, leading to a hemolytic transfusion reaction. Similarly, if a Sid negative woman is pregnant with a Sid positive fetus, the mother's immune system may produce anti-Sid antibodies, potentially leading to hemolytic disease of the newborn.
Testing[edit | edit source]
Testing for the Sid blood group system is performed using serological methods. The presence or absence of the Sid antigen is determined by testing the patient's red blood cells with anti-Sid serum. If the red blood cells agglutinate, the patient is considered Sid positive. If no agglutination occurs, the patient is considered Sid negative.
See also[edit | edit source]
- Blood group system
- Blood transfusion
- Hemolytic disease of the newborn
- Hemolytic transfusion reaction
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
